(X)

TELL US WHAT YOU THINK

Contact Us:

Midwest Health Initiative
8888 Ladue Road, Suite 250
St. Louis, MO 63124
314.721.7800
info@midwesthealthinitiative.org
* :
* :
* :
:
:
:
: : :
:
* Required
Share this site
Text Size A- A A+





Defeat Diabetes

Disparities and Opportunities in Missouri's Commercially Insured Population

In 2019, the prevalence of people being treated for type 2 diabetes among commercially insured Missourians ages 18 to 64, as measured by MHI claims data was 5.2%. Although those with employer sponsored health care coverage fare better than the broader population when it comes to a chronic illness like diabetes, social factors as well as age were found to be associated with the prevalence and care management of type 2 diabetes, even among the commercially insured.

The study reveals that geography matters in targeting interventions at the local level. MHI found that type 2 diabetes prevalence among working adults varied by Missouri county, and that socio-demographic factors accompanied those differences.

MHI performed statistical analysis on several key areas of interest in diabetes management, using the Robert Graham Center’s Social Deprivation Index (SDI). The index is a composite measure that blends demographic characteristics including income, race, educational attainment, and access to transportation, in order to identify levels of social disadvantage at the county level.

One of the study’s findings reveals that commercially insured adults in Missouri who lived in counties with higher SDI values, in aggregate received fewer recommended diabetes screenings (Hemoglobin A1c, Kidney Function and Cholesterol) than did their neighboring counterparts who lived in areas with a lower SDI, even though both groups were commercially insured.

The report poses policy considerations and urges healthcare leaders to target interventions at the local level, while viewing health outcomes through a community lens. “Small changes, community by community, employer by employer, family by family, can add up to meaningful improvements in health outcomes across the state,” said Marla Langenhorst, Director Benefits, Ameren Corporation and recent past Chair, St. Louis Chapter of the American Diabetes Association.  

Click here to view report


   
Key Findings

1. Prevalence of people being treated
    for type 2 diabetes among
    commercially insured Missourians
    aged 18-64 was 5.2% in 2019.

2. 70% of those with a regular source
    of primary care received three
    recommended diabetes screenings
    during the year.

3. Adjusting for age and health risk,
    people with type 2 diabetes were
    about 2 times more likely to visit
    the emergency department and
    2.7 times more likely to be
    hospitalized in comparison to
    people without diabetes.

4. Medication adherence is an
    improvement opportunity. People
    with type 2 diabetes did not
    consistently refill blood pressure
    (32%), cholesterol (40%), and
    anti-diabetes medications (26%).

5. The average annual cost of a
    person with Type 2 diabetes
    ($14,791) was over 2.5 times
    higher than those without
    diabetes ($5,568).

6. This study’s statistical models show
    that social factors as well as age
    were associated with type 2
    diabetes prevalence and care
    management.

7.
By understanding disease
    prevalence, gaps in care, and
    spending at a local level, resources
    can be targeted to areas with the
    greatest opportunities for
    improvement.